These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2869542)

  • 1. Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats.
    Parale MP; Kulkarni SK
    Psychopharmacology (Berl); 1986; 88(2):237-9. PubMed ID: 2869542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats.
    Kunchandy J; Kulkarni SK
    Psychopharmacology (Berl); 1986; 90(2):198-202. PubMed ID: 2878459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
    Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
    Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial.
    San L; Camí J; Peri JM; Mata R; Porta M
    Br J Addict; 1990 Jan; 85(1):141-7. PubMed ID: 1968773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clonidine and related substances on voluntary ethanol consumption in rats.
    Opitz K
    Drug Alcohol Depend; 1990 Feb; 25(1):43-8. PubMed ID: 1969792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats.
    Buccafusco JJ; Marshall DC; Turner RM
    Life Sci; 1984 Sep; 35(13):1401-8. PubMed ID: 6148677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat.
    Thoolen MJ; Hendriks JC; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1983; 5(2):224-8. PubMed ID: 6188894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: suppression by alpha 2-adrenoceptor stimulation.
    van der Laan JW; Weick G; Hillen FC
    Psychopharmacology (Berl); 1983; 81(3):267-71. PubMed ID: 6139840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two alpha-noradrenergic agonists (clonidine and guanfacine) on norepinephrine turnover in the cortex of rats during morphine abstinence.
    Zigun JR; Bannon MJ; Roth RH
    Eur J Pharmacol; 1981 Apr; 70(4):565-70. PubMed ID: 6113150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of guanfacine treatment of acute opiate withdrawal.
    Schubert H; Fleischhacker WW; Meise U; Theohar C
    Am J Psychiatry; 1984 Oct; 141(10):1271-3. PubMed ID: 6148895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alpha2 agonists clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats.
    Kunchandy J; Khanna S; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):123-38. PubMed ID: 2862848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
    Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
    Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats.
    Kulkarni SK; Mehta AK; Kunchandy J
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):324-34. PubMed ID: 3516094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between central alpha 1- and alpha 2-adrenoceptors on sympathetic tone in rats.
    Huchet AM; Huguet F; Tsoucaris-Kupfer D; Legrand M; Narcisse G
    Neuropharmacology; 1986 May; 25(5):509-14. PubMed ID: 3016587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of alpha 2 adrenoceptor agonists on Ro 5-4864-induced convulsions in rats and mice.
    Kunchandy J; Kulkarni SK
    Psychopharmacology (Berl); 1987; 93(1):113-7. PubMed ID: 2819922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alpha 2-adrenoceptor agonists on the expression of morphine-withdrawal in rats.
    Coupar IM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):553-7. PubMed ID: 1356234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites.
    Johnston AL; File SE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):151-6. PubMed ID: 2567522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of heroin withdrawal with guanfacine: an open clinical investigation.
    Soler Insa PA; Bedate Villar J; Theohar C; Yotis A
    Can J Psychiatry; 1987 Nov; 32(8):679-82. PubMed ID: 2891431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha 2-agonists on morphine withdrawal behaviour: potentiation of jumping mediated by alpha 2-receptors.
    van der Laan JW
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):293-8. PubMed ID: 2862592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alpha-adrenoreceptors in the control of spontaneous motility and morphine withdrawal syndrome.
    Antonelli T; Morari M; Magri A; Bianchi C
    Boll Soc Ital Biol Sper; 1991; 67(10-11):965-71. PubMed ID: 1687951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.